Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review - Université Paris Cité Accéder directement au contenu
Article Dans Une Revue European Neuropsychopharmacology Année : 2022

Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review

1 Medical University Graz
2 University of Cagliari
3 Dalhousie University [Halifax]
4 University of Barcelona
5 Frankfurt University Hospital
6 NIMH - National Institute of Mental Health [Klecany, Czech Republic]
7 GU - Göteborgs Universitet = University of Gothenburg
8 Karolinska Institutet [Stockholm]
9 Charité - UniversitätsMedizin = Charité - University Hospital [Berlin]
10 Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
11 Newcastle University [Newcastle]
12 OPTeN (UMR_S 1144 / U1144) - Optimisation thérapeutique en Neuropsychopharmacologie
13 CHU Pitié-Salpêtrière [AP-HP]
14 Hôpital Lariboisière-Fernand-Widal [APHP]
15 Universität Heidelberg [Heidelberg] = Heidelberg University
16 MSSM - Icahn School of Medicine at Mount Sinai [New York]
17 Erasmus MC - Erasmus University Medical Center [Rotterdam]
18 UPV / EHU - University of the Basque Country = Euskal Herriko Unibertsitatea
19 UEA - University of East Anglia [Norwich]
20 UCPH - University of Copenhagen = Københavns Universitet
21 UNISI - Università degli Studi di Siena = University of Siena
22 TU Dresden - Technische Universität Dresden = Dresden University of Technology
23 University of Oxford
24 Bioaraba Health Research Institute
25 VU - Vrije Universiteit Amsterdam [Amsterdam]
26 LMU - Ludwig-Maximilians University [Munich]
27 Oslo University Hospital [Oslo]
28 DEÜ - Dokuz Eylül Üniversitesi = Dokuz Eylül University [Izmir]
29 GHU Paris Psychiatrie et Neurosciences
30 NTNU - Norwegian University of Science and Technology
31 AAU - Aalborg University [Denmark]
32 UiO - University of Oslo
Guy Goodwin
  • Fonction : Auteur

Résumé

Bipolar disorder (BD) might be associated with higher infection rates of coronavirus disease (COVID-19) which in turn could result in worsening the clinical course and outcome. This may be due to a high prevalence of somatic comorbidities and an increased risk of delays in and poorer treatment of somatic disease in patients with severe mental illness in general. Vaccination is the most important public health intervention to tackle the ongoing pandemic. We undertook a systematic review regarding the data on vaccinations in individuals with BD. Proportion of prevalence rates, efficacy and specific side effects of vaccinations and in individuals with BD were searched. Results show that only five studies have investigated vaccinations in individuals with BD, which substantially limits the interpretation of overall findings. Studies on antibody production after vaccinations in BD are very limited and results are inconsistent. Also, the evidence-based science on side effects of vaccinations in individuals with BD so far is poor.
Fichier principal
Vignette du fichier
1-s2.0-S0924977X21007434-main.pdf (918.55 Ko) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

inserm-03847268 , version 1 (10-11-2022)

Identifiants

Citer

Eva Reininghaus, Mirko Manchia, Nina Dalkner, Nina Bonkat, Alessio Squassina, et al.. Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review. European Neuropsychopharmacology, 2022, 54, pp.90-99. ⟨10.1016/j.euroneuro.2021.09.001⟩. ⟨inserm-03847268⟩
28 Consultations
28 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More